Miguel-Angel Perales, MD
Bone Marrow Transplant Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Bone Marrow Transplantation
- Immunotherapy and Cancer Vaccines
- CAR T Cell Therapy
About Me
- Chief, Adult Bone Marrow Transplant Service
I am a board-certified medical oncologist with expertise in donor-derived hematopoietic (blood-forming) stem cell transplantation. Hematopoietic stem cells from a donor other than the patient can cure many patients who have diseases of the blood and bone marrow, including leukemias and lymphomas. The donor stem cells can come from different sources (related or unrelated donors, and bone marrow, peripheral blood, or umbilical cord blood units) and can be modified in different ways before transplantation to enhance their effectiveness.
Read more
Along with colleagues here, I am participating in a number of studies designed to improve outcomes in patients undergoing stem cell transplantation, including finding ways to lower the risk of complications, relapse, and graft-versus-host disease. In particular, I am leading a clinical trial in patients who have advanced Hodgkin lymphoma; the goal of the trial is to determine the safest way to perform a transplant using stem cells from a donor in patients with relapsed Hodgkin lymphoma.
I also conduct translational clinical research investigating new ways to enhance the recovery of the immune system after a transplant and ways to help the immune system fight hematologic malignancies. My colleagues and I are investigating new agents such as interleukin-7 and KGF to enhance immune recovery, as well as new approaches to generate specialized T cells that will specifically target hematologic malignancies.
My practice consists of patients with a variety of hematologic malignancies who are in need of an allogeneic transplant, including patients with acute myelogenous leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, non-Hodgkin lymphoma, and Hodgkin lymphoma. The goal of my practice and clinical research is to be able to offer every patient in need of a transplant the opportunity to undergo this potentially curative therapy.
A bone marrow transplant specialist is a doctor with special training in bone marrow transplants.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Bone Marrow Transplantation
- Immunotherapy and Cancer Vaccines
- CAR T Cell Therapy
Education
- MD, Free University of Brussels
Residencies
- Internal Medicine, Tufts-New England Medical Center
Fellowships
- Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center
- Medicine, Weill Cornell Medical College
Board Certifications
- Internal Medicine, Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Perales sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Perales
- A Phase II Study of MB-CART2019.1 CAR T-Cell Therapy in People with Diffuse Large B-Cell Lymphoma
- Clinical Trials Co-Investigated by Dr. Perales
- A Phase I/II Study of SMART101 in Children and Adults with Acute Leukemia Who Receive a T-Cell Depleted Stem Cell Transplant from a Donor
- A Phase II Study of JCAR017 in People with Recurrent or Persistent Follicular Lymphoma or Marginal Zone Lymphoma
- A Phase II Study of Mismatched Unrelated Donor Stem Cell Transplantation in People with Blood Cancers
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Perales’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Miguel-Angel Perales discloses the following relationships and financial interests:
-
AiCuris Anti-infective Cures AG
Professional Services and Activities (Uncompensated) -
Allogene Therapeutics
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
Caribou Biosciences, Inc.
Professional Services and Activities (Uncompensated) -
Celgene
Professional Services and Activities -
Cidara Therapeutics, Inc.
Professional Services and Activities -
CoImmune, Inc.
Professional Services and Activities -
ImmPACT Bio USA Inc.
Professional Services and Activities (Uncompensated) -
Incyte
Professional Services and Activities -
Iovance Biotherapeutics, Inc.
Professional Services and Activities -
Jasper Therapeutics Inc.
Professional Services and Activities -
Jazz Pharmaceuticals
Professional Services and Activities (Uncompensated)
-
Kite Pharmaceuticals
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities -
Miltenyi Biotec Incorporated
Professional Services and Activities -
Nektar Therapeutics
Professional Services and Activities -
NexImmune
Equity; Professional Services and Activities (Uncompensated) -
Novartis
Professional Services and Activities -
Omeros
Equity; Professional Services and Activities -
Orca Biosystems, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Sanofi S.A.
Professional Services and Activities -
Sellas Life Science Group
Professional Services and Activities -
VectivBio AG
Professional Services and Activities (Uncompensated) -
Vor Biopharma Inc.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].